Literature DB >> 20588162

Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients.

Alba Diaz1, Llúcia Alós, Agathe León, Anna Mozos, Miguel Caballero, Antonio Martinez, Montserrat Plana, Teresa Gallart, Cristina Gil, Manuel Leal, Jose M Gatell, Felipe García.   

Abstract

OBJECTIVE: The factors associated with fibrosis in lymphoid tissue in long-term treated HIV-infected patients and their correlation with immune reconstitution were assessed.
METHODS: Tonsillar biopsies were performed in seven antiretroviral-naive patients and 29 successfully treated patients (median time on treatment, 61 months). Twenty patients received protease inhibitors-sparing regimens and nine protease inhibitor-containing regimens. Five tonsillar resections of HIV-negative individuals were used as controls. Lymphoid tissue architecture, collagen deposition (fibrosis) and the mean interfollicular CD4(+) cell count per mum were assessed.
RESULTS: Naive and long-term treated HIV-infected patients had a higher proportion of fibrosis than did HIV-uninfected persons (P < 0.001). Patients with greater collagen deposition showed lower levels of CD4 cells in lymphoid tissue (P = 0.03) and smaller increase in peripheral CD4(+) T cells (r = -0.40, P = 0.05). The factors independently associated with fibrosis in lymphoid tissue were age (P < 0.0001), treated patients with detectable lymphoid tissue viral load when compared with patients with undetectable lymphoid tissue viral load (median 5 vs. 12%, respectively, P = 0.017) and patients receiving a protease inhibitor-sparing vs. a protease inhibitor-containing regimen (median 8 vs. 2.5%, respectively, P = 0.04).
CONCLUSION: Fibrosis in lymphoid tissue was associated with a poor reconstitution of CD4(+) T cells and long-term antiretroviral therapy did not reverse this abnormality. HIV infection, older age, a detectable level of lymphoid tissue viral load in treated patients and protease inhibitor-sparing regimens seem to favour fibrosis in lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588162     DOI: 10.1097/QAD.0b013e32833c3268

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial.

Authors:  Berta Torres; Norma I Rallón; Montserrat Loncá; Alba Díaz; Llucia Alós; Esteban Martínez; Anna Cruceta; Joan Albert Arnaiz; Lorna Leal; Constanza Lucero; Agathe León; Marcelo Sánchez; Eugenia Negredo; Bonaventura Clotet; José M Gatell; José M Benito; Felipe Garcia
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-10       Impact factor: 2.205

2.  Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model.

Authors:  Jasmine Samal; Samantha Kelly; Ali Na-Shatal; Abdallah Elhakiem; Antu Das; Ming Ding; Anwesha Sanyal; Phalguni Gupta; Kevin Melody; Brad Roland; Watfa Ahmed; Aala Zakir; Moses Bility
Journal:  JCI Insight       Date:  2018-09-20

Review 3.  Imaging lymphoid tissues in nonhuman primates to understand SIV pathogenesis and persistence.

Authors:  Claire Deleage; Baris Turkbey; Jacob D Estes
Journal:  Curr Opin Virol       Date:  2016-08-01       Impact factor: 7.090

4.  Role of intestinal myofibroblasts in HIV-associated intestinal collagen deposition and immune reconstitution following combination antiretroviral therapy.

Authors:  David M Asmuth; Irina V Pinchuk; Jian Wu; Gracie Vargas; Xiaoli Chen; Surinder Mann; Anthony Albanese; Zhong-Min Ma; Ramez Saroufeem; Gregory P Melcher; Paolo Troia-Cancio; Natalie J Torok; Christopher J Miller; Don W Powell
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

5.  Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors.

Authors:  Alba Diaz; Felipe García; Anna Mozos; Miguel Caballero; Agathe León; Antonio Martinez; Cristina Gil; Montserrat Plana; Teresa Gallart; Jose M Gatell; Llúcia Alós
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

6.  Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.

Authors:  Zhenwu Luo; Zhen Li; Lisa Martin; Zhuang Wan; Eric G Meissner; Enrique Espinosa; Hao Wu; Xiaocong Yu; Pingfu Fu; Maria Anna Julia Westerink; J Michael Kilby; Jennifer Wu; Lei Huang; Sonya L Heath; Zihai Li; Wei Jiang
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

7.  Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.

Authors:  Sophia Swanson; Yifei Ma; Rebecca Scherzer; Greg Huhn; Audrey L French; Michael W Plankey; Carl Grunfeld; William M Rosenberg; Marion G Peters; Phyllis C Tien
Journal:  J Infect Dis       Date:  2015-11-29       Impact factor: 5.226

8.  A link between IL-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.

Authors:  Zhenwu Luo; Min Li; Fuli Mi; Zhefeng Meng; Guoqiang Du; Lisa Martin; Hui Liu; Ping Jin; David Stroncek; Sonya L Heath; Wei Jiang
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

9.  Increased inflammation in sanctuary sites may explain viral blips in HIV infection.

Authors:  E Fabian Cardozo; Michael J Piovoso; Ryan Zurakowski
Journal:  IET Syst Biol       Date:  2016-08       Impact factor: 1.615

Review 10.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.